ANI PHARMACEUTICALS INC 8-K

What Happened
ANI Pharmaceuticals, Inc. (ANIP) filed a Form 8-K on March 3, 2026 (Item 7.01, Regulation FD Disclosure) stating that the company and members of its executive leadership team will present at the Raymond James & Associates’ 47th Annual Institutional Investors Conference in Orlando, Florida. The filing attaches an updated investor presentation (Exhibit 99.1, dated March 2026) that the company says it may use in other investor and analyst meetings.

Key Details

• Form 8-K filed March 3, 2026; disclosure made under Item 7.01 (Regulation FD).
• The presentation will be used at the Raymond James 47th Annual Institutional Investors Conference (Orlando, FL).
• Updated investor presentation included as Exhibit 99.1, dated March 2026.
• Company notes the presentation may be used in various investor/analyst meetings going forward.

Why It Matters
This 8-K provides investors access to ANI’s latest investor presentation and confirms management will be presenting at a major institutional investor conference—opportunities for updated company commentary and outreach. The filing is a routine Regulation FD disclosure of investor materials and does not report earnings, executive changes, or other material corporate transactions.